NASDAQ: MDCX
Medicus Pharma Ltd Stock Ownership - Who owns Medicus Pharma?

Insider buying vs selling

Have Medicus Pharma Ltd insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Velocity Fund Partners LP10% Owner2025-05-2075,000$7.72
$578.93kSell

1 of 1

MDCX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when MDCX insiders and whales buy or sell their stock.

MDCX Shareholders

What type of owners hold Medicus Pharma Ltd stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Velocity Fund Partners LP24.63%3,323,741$11.23MInsider
Kenneth R. Melani24.63%3,323,741$11.23MInsider
Ajay Raju14.82%2,000,000$6.76MInsider
Interchange Capital Partners LLC12.31%1,661,871$5.62MInstitution
Armistice Capital LLC9.38%1,266,000$4.28MInstitution
Raza Bokhari5.88%793,173$2.68MInsider
James P. Quinlan0.96%129,147$436.52kInsider
Edward J. Brennan0.64%86,500$292.37kInsider
Private Advisor Group LLC0.42%56,750$191.82kInstitution
Patriot Investment Management Group Inc0.22%29,203$98.71kInstitution

1 of 2

MDCX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
MDCX22.53%71.99%Net SellingNet Selling
XCUR0.50%99.50%Net BuyingNet Selling
OSTX1.39%23.50%Net SellingNet Selling
KLTO2.60%14.08%
MURA48.61%3.32%Net SellingNet Selling

Medicus Pharma Stock Ownership FAQ

Who owns Medicus Pharma?

Medicus Pharma (NASDAQ: MDCX) is owned by 22.53% institutional shareholders, 71.99% Medicus Pharma insiders, and 5.49% retail investors. Velocity Fund Partners LP is the largest individual Medicus Pharma shareholder, owning 3.32M shares representing 24.63% of the company. Velocity Fund Partners LP's Medicus Pharma shares are currently valued at $11.23M.

If you're new to stock investing, here's how to buy Medicus Pharma stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.